Boothbay Fund Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Boothbay Fund Management's GSK Position: Q3 2026 in Review
Boothbay Fund Management sold out of GSK (GSK) in Q3 2026, closing a stake of 156,400 shares — an estimated $8.2M sold.
Boothbay Fund Management first reported a position in GSK in Q3 2021 and held it in 12 quarters. The position peaked at $29.7M in Q2 2023. 990 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Boothbay Fund Management reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
- Boothbay Fund Management sold 156,400 GSK shares in Q3 2026, an estimated $8.2M.
- Boothbay Fund Management first reported a position in GSK in Q3 2021 and held it in 12 quarters.
- Boothbay Fund Management's GSK position peaked at $29.7M in Q2 2023.
- 990 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.